Study Summary:
We are currently conducting a 26-week double-blind and a 26-week open label trial of a new NSAID for patients with osteoarthritis of the knee.
Qualified Participants Must:
• Be 40 years of age or older
•
Be taking daily medication for osteoarthritis of the knee
•
Agree to X-ray of the knee
Qualified Participants May Receive:
Free medication, study visits, and compensation for time and travel.